Guggenheim Initiates Coverage On Zymeworks with Buy Rating, Announces $48 Price Target

Guggenheim initiates coverage on Zymeworks (NYSE:ZYME) with a Buy rating and a $48 price target.

Benzinga · 11/20/2019 11:52

Guggenheim initiates coverage on Zymeworks (NYSE:ZYME) with a Buy rating and a $48 price target.